Although differences in PPF-related HRCT findings were not observed between the anti-MDA5 antibody-positive and antibody-negative groups, pulmonary fibrosis in anti-MDA5 antibody-positive ILD progressed rapidly within six months, despite immunosuppressive therapy. Here, IFIH1 is linked to interstitial lung disease.